Posted by: APO | 29 November 2016

First New HIV Vaccine Efficacy Study in Seven Years Has Begun

The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. The study, called HVTN 702, involves a new version of the only HIV vaccine candidate ever shown to provide some protection against the virus. HVTN 702 aims to enroll 5,400 men and women, making it the largest and most… Read more on


%d bloggers like this: